irinotecan has been researched along with benzeneboronic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Hou, B; Hu, X; Lai, Y; Lei, L; Tian, Y; Wang, Y; Xu, J; Xu, Z; Yu, H; Zhang, W | 1 |
Che, R; Lu, W; Zhang, Q | 1 |
Chen, M; Chen, Q; Deng, W; Gong, Y; Jin, Q; Liu, Z; Shen, J; Sun, J; Tan, Y; Wang, C | 1 |
3 other study(ies) available for irinotecan and benzeneboronic acid
Article | Year |
---|---|
Bioinspired Multivalent Peptide Nanotubes for Sialic Acid Targeting and Imaging-Guided Treatment of Metastatic Melanoma.
Topics: Animals; Boronic Acids; Humans; Irinotecan; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; N-Acetylneuraminic Acid; Nanotubes, Peptide; Topoisomerase I Inhibitors | 2019 |
Enhanced cellular uptake efficiency of DCM probes or SN38 conjugating with phenylboronic acids.
Topics: A549 Cells; Antineoplastic Agents; Biological Transport; Boronic Acids; Cell Proliferation; Drug Design; Fluorescent Dyes; Hep G2 Cells; Humans; Irinotecan; Molecular Structure; Pyrans | 2020 |
Injectable Reactive Oxygen Species-Responsive SN38 Prodrug Scaffold with Checkpoint Inhibitors for Combined Chemoimmunotherapy.
Topics: Animals; Antineoplastic Agents; Boronic Acids; Cell Death; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Female; Immunotherapy; Irinotecan; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Molecular Structure; Particle Size; Polyvinyl Alcohol; Prodrugs; Programmed Cell Death 1 Receptor; Reactive Oxygen Species; Surface Properties; T-Lymphocytes | 2020 |